- Home
- TELO
as 11-15-2024 4:00pm EST
Stocks
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.
| Founded: | 2021 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 124.1M | IPO Year: | 2024 |
| Target Price: | N/A | AVG Volume (30 days): | 61.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.79 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.11 - $20.72 | Next Earning Date: | 11-12-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest TELOMIR PHARMACEUTICALS INC News
TELO Breaking Stock News: Dive into TELO Ticker-Specific Updates for Smart Investing
ACCESSWIRE
2 months ago
Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday
Simply Wall St.
2 months ago
Telomir Pharmaceuticals Insider Ups Holding During Year
ACCESSWIRE
2 months ago
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications
ACCESSWIRE
3 months ago
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs
MT Newswires
3 months ago
Telomir Pharmaceuticals' CEO Christopher Chapman Dies; Erez Aminov to Succeed
GlobeNewswire
3 months ago
Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman
Simply Wall St.
3 months ago
Individual investors are Telomir Pharmaceuticals, Inc.'s (NASDAQ:TELO) biggest owners and were rewarded after market cap rose by US$24m last week
MT Newswires
5 months ago
Telomir Pharmaceuticals Joins Russell 3000, Microcap Indexes
Compare TELO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TELO TELOMIR PHARMACEUTICALS INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.